Low risk of hepatitis e among Dutch short-term travelers

Journal of Travel Medicine

Volumn 19, Issue 3, 2012, Pages 202-204

  Elfrink, Floor ^a,b   Van Rijckevorsel, Gini G C ^a,b   Van Gool, Tom ^c   Van Den Hoek, Anneke ^a,c   Sonder, Gerard J B ^a,b,c  

^a DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

^b National Coordination Centre for Traveler's Health Advice LCR   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS E ANTIBODY;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DENMARK; FEMALE; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NAMED GROUPS OF PERSONS; POPULATION RISK; PROSPECTIVE STUDY; SEROCONVERSION; TRAVELER; TROPICS; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEPATITIS E; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PROSPECTIVE STUDIES; RISK; SEROEPIDEMIOLOGIC STUDIES; TIME FACTORS; TRAVEL; TROPICAL CLIMATE;

EID: 84860247336     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2012.00597.x     Document Type: Article

References (10)

1. Piper-Jenks N, Horowitz HW, Schwartz E., Risk of hepatitis E infection to travelers. J Trav Med 2000; 7: 194-199.
2. Aggarwal R., Hepatitis E: historical, contemporary and future perspectives. J Gastroenterol Hepatol 2011; 26: 72-82.
3. Lu L, Li C, Hagedorn CH., Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev Med Virol 2006; 16: 5-36.
4. Potasman I, Koren L, Peterman M, Srugo I., Lack of hepatitis E infection among backpackers to tropical countries. J Trav Med 2000; 7: 208-210.
5. Ooi WW, Gawoski JM, Yarbough PO, Pankey GA., Hepatitis E seroconversion in United States travelers abroad. Am J Trop Med Hyg 1999; 61: 822-824.
6. Bendall R, Ellis V, Ijaz S, et al., A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol 2010; 82: 799-805.
7. Herremans M, Bakker J, Duizer E, et al., Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity. Clin Vaccine Immunol 2007; 14: 562-568.
8. Belderok SM, van den Hoek JAR, Kint JA, et al., Incidence, risk factors and treatment of diarrhoea among Dutch travellers: reasons not to routinely prescribe antibiotics. BMC Infect Dis 2011; 11: 295.
9. Waar K, Herremans MM, Vennema H, et al., Hepatitis E is a cause of unexplained hepatitis in The Netherlands. J Clin Virol 2005; 33: 145-149.
10. Bouwknegt M, Engel B, Herremans MM, et al., Bayesian estimation of hepatitis E virus seroprevalence for populations with different exposure level to swine in The Netherlands. Epidemiol Infect 2008; 136: 567-576.